These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1900419)

  • 1. alpha-L-iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts.
    Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):263-8. PubMed ID: 1900419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
    Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
    Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.
    Kakkis ED; Matynia A; Jonas AJ; Neufeld EF
    Protein Expr Purif; 1994 Jun; 5(3):225-32. PubMed ID: 7950365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
    Unger EG; Durrant J; Anson DS; Hopwood JJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
    Hopwood JJ; Muller VJ
    Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A canine model of human alpha-L-iduronidase deficiency.
    Spellacy E; Shull RM; Constantopoulos G; Neufeld EF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6091-5. PubMed ID: 6412235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
    Muller VJ; Hopwood JJ
    Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
    Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.
    Clements PR; Brooks DA; McCourt PA; Hopwood JJ
    Biochem J; 1989 Apr; 259(1):199-208. PubMed ID: 2470345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hurler syndrome: a patient with abnormally high levels of alpha-L-iduronidase protein.
    Brooks DA; Harper GS; Gibson GJ; Ashton LJ; Taylor JA; McCourt PA; Freeman C; Clements PR; Hoffmann JW; Hopwood JJ
    Biochem Med Metab Biol; 1992 Jun; 47(3):211-20. PubMed ID: 1627351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities.
    Schuchman EH; Desnick RJ
    J Clin Invest; 1988 Jan; 81(1):98-105. PubMed ID: 3121676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hurler syndrome: detection of patients and heterozygotes using a microassay for alpha-L-iduronidase in fibroblasts.
    Kleijer WJ; Hensing-Wolffers GM; Thompson EJ; Niermeijer MF
    Clin Chim Acta; 1981 Oct; 116(1):47-54. PubMed ID: 6797759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.
    Bunge S; Clements PR; Byers S; Kleijer WJ; Brooks DA; Hopwood JJ
    Biochim Biophys Acta; 1998 Sep; 1407(3):249-56. PubMed ID: 9748610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
    Hopwood JJ
    Carbohydr Res; 1979 Mar; 69():203-16. PubMed ID: 106967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors.
    Di Natale P; Di Domenico C; Villani GR; Lombardo A; Follenzi A; Naldini L
    Eur J Biochem; 2002 Jun; 269(11):2764-71. PubMed ID: 12047386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosidase active site mutations in human alpha-L-iduronidase.
    Brooks DA; Fabrega S; Hein LK; Parkinson EJ; Durand P; Yogalingam G; Matte U; Giugliani R; Dasvarma A; Eslahpazire J; Henrissat B; Mornon JP; Hopwood JJ; Lehn P
    Glycobiology; 2001 Sep; 11(9):741-50. PubMed ID: 11555618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V; Smithson A; Baggett N
    Clin Chim Acta; 1979 Mar; 92(2):257-65. PubMed ID: 114339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.
    Hein LK; Hopwood JJ; Clements PR; Brooks DA
    Biochim Biophys Acta; 2003 Oct; 1639(2):95-103. PubMed ID: 14559116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.